Helping to Raise Awareness of Colorectal Cancer
Georgetown Lombardi member Aiwu Ruth He, MD, PhD (left), joined other volunteers including Martha Raymond (right), founder/CEO of The Raymond Foundation, to help plant 27,400 blue flags on the National Mall for Fight Colorectal Cancer’s United in Blue installation. The installation, part of an effort to raise awareness of colorectal cancer and its impact, is a visual reminder that in 2030, more than 27,400 people under age 50 are projected to be diagnosed with the disease. It on is display through March 24.
|
|
GHUCCTS Presents Responsible Conduct of Research Series
-
April 6: “Research Misconduct and Policies for Handling Misconduct”
-
April 13: “Conflict of Interest (Personal, Professional, and Financial) and Collaborative Research Including Collaborations with Industry”
-
May 4: “Authorship and Publication”
-
May 11: “Mentorship and Mentee Responsibilities and Relationships - Mentor-Mentee Contracts”
-
June 1: “Policies Regarding Human Subjects, Live Vertebrate Animals, Safe Laboratory Practices”
|
|
Shared Resources Spotlight |
|
This weekly series showcases Georgetown University’s Shared Resources, which provide Georgetown Lombardi researchers with access to state-of-the-art equipment and technical expertise to support their work. |
|
Microscopy and Imaging Shared Resource
The Microscopy and Imaging Shared Resource (MISR) provides Georgetown Lombardi investigators with access to advanced microscopy and imaging-based technologies and analysis packages. Imaging approaches supported on the D.C. campus include bright-field microscopy (including phase and DIC), wide-field fluorescence microscopy, laser scanning and spinning disk confocal microscopy of fixed and living samples, including FRET, FRAP, and second and third harmonic generation imaging. In addition, Stimulated Emission Depletion (STED) and SoRa-based super resolution imaging, enhanced FLIM imaging, and high-speed TIRF imaging and microscopy-based metabolic imaging systems are available. The MISR in New Jersey is equipped with four Nikon Ti2 imaging platforms offering LSM confocal, wide-field fluorescence and bright-field imaging, two Leica confocal microscopes (Stellaris 5 and Stellaris 8). The expert faculty and staff in the MISR offer advice and assistance with experimental design, the selection of optimal reagents, appropriate technology, and analytical approaches.
New technology now available: The Nikon CSU-W1 SoRa confocal field scanning spinning disk/confocal super resolution system is ideal for live cell or organism applications. An ONI Nanoimager super resolution microscope that can perform dSTORM/PALM, smFRET and single particle tracking imaging is now available in the MISR-NJ.
|
|
Tuesday, March 21
4:00 - 5:00 p.m.
Presented by Robert Star, MD, director, Division of Kidney, Urologic, & Hematologic Diseases, section chief, Renal Diagnostics and Therapeutics Unit, Kidney Diseases Branch, NIDDK, NIH. Join this lecture in the New Research Building Auditorium or via Zoom.
|
|
Thursday, March 23
8:30 a.m. - 2:00 p.m.
A workshop for research personnel interested in enhancing their competency in the field of clinical research. Sponsored by Georgetown-Howard Universities Center for Clinical Translational Science (GHUCCTS) - Regulatory, Ethics, and Knowledge Support Group (REKS). Registration required. This event will take place in-person at the Louis Stokes Library at Howard University.
|
|
CENTILE Grand Rounds: “Using Art as a Catalyst to Reflect About Uncertainty and Ambiguity in Medicine“
Thursday, March 23
12:00 - 1:00 p.m.
Presented by Götz Fabry, MD, MHPE, senior lecturer, Department of Medical Psychology and Medical Sociology, Faculty of Medicine, Albert-Ludwigs-University in Freiburg, Germany. Register to join this talk via Zoom.
|
|
Thursday, March 23
4:00 - 5:00 p.m.
Presented by Joni Rutter, PhD, director, National Center for Advancing Translational Sciences, National Institutes of Health. Join this seminar in the New Research Building Auditorium or via Zoom.
|
|
Friday, March 24
12:00 - 1:00 p.m.
|
|
Monday, March 27
10:00 - 11:00 a.m.
|
|
Funding and Award Opportunities |
|
NEW Request for Applications: Pediatric Sarcomas
The Samuel Waxman Cancer Research Foundation, Alan B. Slifka Foundation and Israel Cancer Research Fund are pleased to issue a joint request for applications for collaborative applications focused on fusion-positive pediatric sarcomas. Note: Projects must involve collaboration between two research groups — one in North America and one in Israel — with different but complementary expertise. Proposals must justify the partnership through synergistic scientific aims. One successful collaborative project will be awarded $150,000 per year for two years, or a total of $300,000, with each university-based research group receiving $75,000 per year ($150,000). Proposals will be prioritized for funding based on their potential to contribute to understanding, preventing and effectively treating pediatric sarcomas, with an emphasis on Ewing sarcoma. View full RFA information. Submit letter of intent by 5 p.m. on May 1, to Wylie Tene at wtene@waxmancancer.org.
|
|
The New York Academy of Sciences - Takeda Innovators in Science Award: Cancer Immunology
The Innovators in Science Award, administered by the New York Academy of Sciences and sponsored by Takeda, is accepting nominations. This global award recognizes the contributions of both a promising early career scientist and an outstanding senior scientist to biomedical science and is intended to support their commitment to innovative research with an unrestricted prize of $200,000. The 2024 Innovators in Science Award will recognize achievements in cancer immunology. View more information. Those interested in submitting a nomination should email their proposal to Sharon Levy (sgl5@georgetown.edu) by March 25.
|
|
ROS1ders Request for Application for ROS1+ Cancer Research Grant
The ROS1+ Cancer Innovation Award funds high-risk, high-reward research projects focused on ROS1+ cancer. The one-year, $75,000 seed grant can be used for preclinical, translational or clinical research and is open to investigators who hold a doctorate degree and a faculty appointment at an academic or nonprofit research institution anywhere in the world. Submit letter of intent by March 31. Invited applicants must submit full application by June 15. View the RFA. Apply online at ProposalCentral.
|
|
Federal Lung Cancer Funding Opportunities
The Lung Cancer Research Program (LCRP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2023 funding opportunities. The LCRP looks to support highly innovative, high-risk early ideas as well as more advanced translation research and early stage clinical trials. In addition, it supports researcher development with a career development-focused award mechanism. Pre-application (letter of intent) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Career Development Award, Pre-application due May 2, 5:00 p.m. ET
-
Concept Award, Pre-application due May 2, 5:00 p.m. ET
-
Idea Development Award: Pre-application due May 10, 5:00 p.m. ET
-
Translational Research Award: Pre-application due May 10, 5:00 p.m. ET
|
|
Children’s Cancer Foundation 2023 Call for Proposals
The Children's Cancer Foundation, Inc. (CCF) invites individuals from Maryland, D.C. and Northern Virginia conducting research and/or programs relevant to pediatric cancer to submit proposals for grant award consideration. CCF will be awarding multiple one-year grants for research; one one-year grant for research by a young investigator (Giant Food NextGen Award); and several one-year grants for support of an existing or new program that serves the pediatric cancer community. Applications must be submitted via email or file transfer service to Rose Ann Verrilli: rverrilli@childrenscancerfoundation.org no later than May 7 at 11:59 p.m. ET. Review and download application materials and guidelines.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | No Conference | Podium A / Zoom
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 81202; phone: 202-796-7323)
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom (dial 646-558-8656; Meeting ID: 941 1630 5835)
12:15 PM | Head and Neck Cancer – Dr. Veytsman | Podium A / Microsoft Teams
|
|
9:00 AM | Cancer Research Data Meeting | Speaker: Christopher Priestley-Milianta | W302 New Research Building or Zoom
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | Onc Path – Drs. Williams and Dunleavy | Podium A / Microsoft Teams
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series: Adrian Lee, PhD, “Precision Medicine Applied to Metastatic Breast Cancer” | Zoom
12:00 PM | No Lecture | Zoom
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
